Insights on common vaccinations in HIV-infection: efficacy and safety

HIV-infected patients are at increased risk for both vaccine-preventable diseases and their complications, with mortality rates higher than in non-HIV-infected individuals. Consequently, international guidelines generally recommend inactivated vaccines in HIV-patients, even if HIV-related immunodefi...

Descripción completa

Detalles Bibliográficos
Autores principales: NICOLINI, L.A., GIACOBBE, D.R., DI BIAGIO, A., VISCOLI, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pacini Editore SpA 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718346/
https://www.ncbi.nlm.nih.gov/pubmed/26789829
_version_ 1782410784736804864
author NICOLINI, L.A.
GIACOBBE, D.R.
DI BIAGIO, A.
VISCOLI, C.
author_facet NICOLINI, L.A.
GIACOBBE, D.R.
DI BIAGIO, A.
VISCOLI, C.
author_sort NICOLINI, L.A.
collection PubMed
description HIV-infected patients are at increased risk for both vaccine-preventable diseases and their complications, with mortality rates higher than in non-HIV-infected individuals. Consequently, international guidelines generally recommend inactivated vaccines in HIV-patients, even if HIV-related immunodeficiency may impair efficacy; live vaccines are usually not recommended in these patients because of safety concerns. The aim of this short article is to review current knowledge about both efficacy and safety of vaccines in HIV-infected individuals.
format Online
Article
Text
id pubmed-4718346
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Pacini Editore SpA
record_format MEDLINE/PubMed
spelling pubmed-47183462016-02-02 Insights on common vaccinations in HIV-infection: efficacy and safety NICOLINI, L.A. GIACOBBE, D.R. DI BIAGIO, A. VISCOLI, C. J Prev Med Hyg Review HIV-infected patients are at increased risk for both vaccine-preventable diseases and their complications, with mortality rates higher than in non-HIV-infected individuals. Consequently, international guidelines generally recommend inactivated vaccines in HIV-patients, even if HIV-related immunodeficiency may impair efficacy; live vaccines are usually not recommended in these patients because of safety concerns. The aim of this short article is to review current knowledge about both efficacy and safety of vaccines in HIV-infected individuals. Pacini Editore SpA 2015-03 /pmc/articles/PMC4718346/ /pubmed/26789829 Text en © Copyright by Pacini Editore SpA, Pisa, Italy http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License, which permits for noncommercial use, distribution, and reproduction in any digital medium, provided the original work is properly cited and is not altered in any way. For details, please refer to http://creativecommons.org/licenses/by-nc-nd/3.0/
spellingShingle Review
NICOLINI, L.A.
GIACOBBE, D.R.
DI BIAGIO, A.
VISCOLI, C.
Insights on common vaccinations in HIV-infection: efficacy and safety
title Insights on common vaccinations in HIV-infection: efficacy and safety
title_full Insights on common vaccinations in HIV-infection: efficacy and safety
title_fullStr Insights on common vaccinations in HIV-infection: efficacy and safety
title_full_unstemmed Insights on common vaccinations in HIV-infection: efficacy and safety
title_short Insights on common vaccinations in HIV-infection: efficacy and safety
title_sort insights on common vaccinations in hiv-infection: efficacy and safety
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718346/
https://www.ncbi.nlm.nih.gov/pubmed/26789829
work_keys_str_mv AT nicolinila insightsoncommonvaccinationsinhivinfectionefficacyandsafety
AT giacobbedr insightsoncommonvaccinationsinhivinfectionefficacyandsafety
AT dibiagioa insightsoncommonvaccinationsinhivinfectionefficacyandsafety
AT viscolic insightsoncommonvaccinationsinhivinfectionefficacyandsafety

Ejemplares similares